Forte Biosciences CEO Paul Wagner's 2023 pay rises 18% to $1.5M
Forte Biosciences reports 2023 executive compensation
By ExecPay News
Published: December 31, 2024
Forte Biosciences reported fiscal year 2023 executive compensation information on December 31, 2024.
In 2023, two executives at Forte Biosciences received on average a compensation package of $1.1M, a 18% increase compared to previous year.
Paul A. Wagner, Chief Executive Officer, received $1.5M in total, which increased by 18% compared to 2022. 43% of Wagner's compensation, or $620K, was in salary. Wagner also received $341K in non-equity incentive plan and $490K in stock awards.
Antony Riley, Chief Financial Officer, received a compensation package of $723K, which increased by 18% compared to previous year. 58% of the compensation package, or $418K, was in salary.